Epialfa 50mg Injection
By Epialfa
Rx
1 Injection in a Vial

Composition
Epirubicin(50mg)

Manufacturer - Metta Life Sciences Private Limited
G-040 Vikas Centre,106, S.V. Road, Santacruz West Mumbai City Mh 400054 India

Expires on or after
June, 2026

liver
When using Epialfa 50mg Injection, caution should be exercised in patients with liver disease. It may be necessary to adjust the dosage of the injection in such cases. It is important to consult your doctor before starting treatment with Epialfa 50mg Injection if you have any liver issues. Patients with severe liver disease are advised not to use Epialfa 50mg Injection. Consulting with your doctor is recommended to ensure the safe use of the medication in liver-related conditions.

kidney
Epialfa 50mg Injection is likely safe for patients with kidney disease. Data suggests dose adjustment may not be necessary. Consult your doctor. Consider lower doses if serum creatinine is > 5 mg/dL.

alcohol
"Avoid consuming alcohol while using Epialfa 50mg Injection due to safety concerns."

driving
Epialfa 50mg Injection can cause side effects like nausea and vomiting, which may affect your ability to drive temporarily.

pregnancy
Epialfa 50mg Injection is not safe to use during pregnancy. It poses a risk to the developing baby. Only in life-threatening situations, the doctor might prescribe it if benefits outweigh risks. Consult your doctor before use.

breastfeeding
Epialfa 50mg Injection is considered unsafe for use while breastfeeding due to the potential risk of causing toxicity to the baby.
Habit Forming | No |
Chemical Class | Anthracycline Derivative |
Therapeutic Class | - |
Action Class | Alkaloids-cytotoxic agents |
₹1500
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025